Arcus Biosciences Inc. (RCUS)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
14.22
0.40 (2.89%)
At close: Jan 15, 2025, 11:55 AM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Cash & Equivalents | 127.00M | 206.00M | 147.91M | 173.41M | 57.94M | 71.06M | 98.43M | 65.16M |
Short-Term Investments | 632.00M | 803.00M | 351.39M | 555.23M | 130.33M | 185.48M | 77.28M | 33.74M |
Long-Term Investments | 107.00M | 129.00M | 181.99M | 6.44M | 203.00K | 4.38M | 682.00K | 1.00M |
Other Long-Term Assets | 106.00M | 114.00M | 591.19M | 7.18M | 872.00K | 487.00K | 1.71M | 403.00K |
Receivables | 42.00M | 43.00M | 745.00M | 1.70M | 132.00K | 83.00K | 25.00K | 405.00K |
Inventory | n/a | -172.00M | -762.44M | -7.17M | n/a | n/a | n/a | n/a |
Other Current Assets | 30.00M | 15.00M | 16.00M | 1.00M | 4.30M | 2.32M | 1.14M | 390.00K |
Total Current Assets | 831.00M | 1.07B | 681.30M | 735.09M | 192.71M | 258.95M | 176.87M | 99.69M |
Property-Plant & Equipment | 51.00M | 35.00M | 137.42M | 23.59M | 9.33M | 11.11M | 11.23M | 8.61M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 264.00M | 278.00M | 910.60M | 37.21M | 10.40M | 15.98M | 13.62M | 10.01M |
Total Assets | 1.09B | 1.34B | 1.59B | 772.29M | 203.11M | 274.93M | 190.49M | 109.70M |
Account Payables | 17.00M | 20.00M | 10.26M | 15.68M | 4.70M | 3.10M | 3.82M | 3.87M |
Deferred Revenue | 91.00M | 97.00M | 102.00M | 74.57M | 7.00M | 6.25M | 5.00M | n/a |
Short-Term Debt | 11.00M | 3.00M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 65.00M | 73.00M | 52.01M | 31.42M | 11.00M | 7.58M | 3.91M | 1.68M |
Total Current Liabilities | 184.00M | 193.00M | 166.08M | 121.67M | 22.71M | 16.93M | 12.73M | 5.55M |
Long-Term Debt | n/a | n/a | 116.89M | 15.24M | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 142.00M | 140.00M | 5.26M | 10.25M | 4.54M | 6.06M | 5.30M | 4.70M |
Total Long-Term Liabilities | 449.00M | 495.00M | 584.36M | 148.32M | 16.56M | 23.05M | 23.89M | 4.70M |
Total Liabilities | 633.00M | 688.00M | 750.45M | 269.99M | 39.27M | 39.98M | 36.62M | 10.24M |
Total Debt | 11.00M | 120.00M | 116.89M | 15.24M | n/a | n/a | n/a | n/a |
Common Stock | 1.31B | 1.21B | 7.00K | 6.00K | 4.00K | 4.00K | 3.00K | 1K |
Retained Earnings | -849.00M | -542.00M | -275.35M | -328.18M | -205.33M | -122.83M | -73.23M | -20.15M |
Comprehensive Income | n/a | -7.00M | -1.26M | 44.00K | 64.00K | -107.00K | -42.00K | -26.00K |
Shareholders Equity | 462.00M | 657.00M | 841.45M | 502.30M | 163.84M | 234.94M | 153.87M | 99.46M |
Total Investments | 739.00M | 932.00M | 533.38M | 561.67M | 130.33M | 189.86M | 77.96M | 34.74M |